Vestmark Advisory Solutions Inc. Purchases 9,815 Shares of CVS Health Corporation $CVS

Vestmark Advisory Solutions Inc. grew its position in CVS Health Corporation (NYSE:CVS) by 154.1% in the third quarter, Holdings Channel.com reports. The fund owned 16,185 shares of the pharmacy operator’s stock after buying an additional 9,815 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in CVS Health were worth $1,220,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of CVS. Harbor Capital Advisors Inc. lifted its position in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC bought a new position in shares of CVS Health during the 3rd quarter worth about $29,000. Front Row Advisors LLC raised its position in CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares in the last quarter. SOA Wealth Advisors LLC. boosted its holdings in CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in shares of CVS Health during the 2nd quarter worth approximately $36,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $76.12 on Thursday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The stock has a market capitalization of $96.84 billion, a P/E ratio of 55.16, a P/E/G ratio of 0.77 and a beta of 0.50. The business has a 50-day moving average price of $78.35 and a two-hundred day moving average price of $77.02.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the previous year, the company earned $1.19 EPS. CVS Health’s revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s dividend payout ratio is presently 192.75%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CVS. The Goldman Sachs Group lifted their price objective on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Wolfe Research boosted their price target on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Piper Sandler restated an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.